UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003702
Receipt number R000004473
Scientific Title Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption
Date of disclosure of the study information 2010/08/01
Last modified on 2010/09/08 11:02:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption

Acronym

Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption

Scientific Title

Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption

Scientific Title:Acronym

Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption

Region

Japan


Condition

Condition

Influenza

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

to confirm mechanism of oral absorption of Tamiflu in healthy male subjects

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

PK profiles of Oseltamivir and it's metabolite Ro64-0802 in plasma and urine

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

The Tamiflu capsule is taken with water.

Interventions/Control_2

The Tamiflu capsule is taken with milk.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >

Gender

Male

Key inclusion criteria

the investigators must ensure that all subjects being considered to meet the following inclusion criteria:
1) healthy male who is capable to understand and sign the informed consent.
2) male between 20 and <45 years of age on the day of signing informed consent
3)Body Mass Indes(BMI) between 17.6 and 26.4 kg/m2 inclusive
4)good health as determined by physical examination and laboratory tests etc.

Key exclusion criteria

the investigators must ensure that all subjects being considered to meet the following exclusion criteria or conditions:
1)history of allergy to Oseltamivir
2)difficult to take milk because of lactose intolerance etc.
3)disease thought to be decreased metabolic function of liver(acute hepatitis,chronic hepatitis,hepatic cirrhosis,liver carcinoma,jaundice)
4)decreased metabolic function of kidney
5)electrocardiogram (ECG) showing a QTc>460 msec
6)who take any drugs or supplement including St.John's wort within a week prior to test drug administration
7)fruit juice including grapefruit, orange or apple within 7 days prior to test drug administration
8)recent (past 3 months) participation in other clinical trial for investigational agent,the investigator determines this trial participation inadequate
9)donation of 400mL or more of blood within 3 months prior to participation, donation of 200mL or more of blood within 1 month prior to participation
10)any positive results of HBs-AG,HCV-AB,HIV AB,HIV AG,TPHA.
11)history of allergy to any medicines and foods
12)history of drug or alcohol abusement
13) the investigator determines inadequate

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takuo Ogihara

Organization

Takasaki University of Health and Welfare

Division name

Faculty of Pharmacy,Department of Pharmaceutical Science ,Biopharmaceutics laboratory

Zip code


Address

60 Nakaoorui-machi,Takasaki-shi,Gunma-ken

TEL

027-352-1180(ext.8311)

Email



Public contact

Name of contact person

1st name
Middle name
Last name Akihiro Inano

Organization

Neues Corporation

Division name

Clinical research support

Zip code


Address

6-18,Tenya machi Hakata-ku,Fukuoka-City

TEL

092-283-7100

Homepage URL


Email

inano.akihiro@neues.co.jp


Sponsor or person

Institute

Takuo Ogihara

Institute

Department

Personal name



Funding Source

Organization

Takasaki University of Health and Welfare

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Medical corporation LTA Sumida Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人 相生会 墨田病院(東京都)


Other administrative information

Date of disclosure of the study information

2010 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 05 Month 11 Day

Date of IRB


Anticipated trial start date

2010 Year 08 Month 01 Day

Last follow-up date

2010 Year 09 Month 01 Day

Date of closure to data entry

2010 Year 09 Month 01 Day

Date trial data considered complete

2010 Year 12 Month 01 Day

Date analysis concluded

2011 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 06 Month 03 Day

Last modified on

2010 Year 09 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004473


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name